Sapirstein James
- SEC CIK
- 0001559509
No open-market purchases or sales filed in the past year.
Current role at each company
- INMB Inmune Bio, Inc.Directoras of Sep 17, 2026
- COCP Cocrystal Pharma, Inc.Chief Executive Officeras of Jun 3, 2026
- ZVSA ZyVersa Therapeutics, Inc.Directoras of Jul 15, 2025
- ONCO Onconetix, Inc.Directoras of Sep 30, 2024
- GRDX GridAI Technologies Corp.Chairman and CEOas of Jul 3, 2024
Show 1 more company
- LNAI Lunai Bioworks Inc.Directoras of Jun 27, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sapirstein James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GRDX GridAI Technologies Corp.
Chairman and CEO7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Sapirstein JamesChairman and CEO | SSale | −1.29K | $1.07 | −$1.38K | −3.5%35.8K after | |
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Sapirstein JamesChairman and CEO | SSale | −174 | $4.23 | −$736.02 | −0.5%37.1K after | |
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Sapirstein JamesChairman and CEO | SSale | −1.89K | $4.96 | −$9.36K | −4.8%37.3K after | |
| Jan 17, 2024 (view filing) | Jan 12 | 5 days | Sapirstein JamesChairman, President and CEO | SSale | −166 | $4.20 | −$697.2 | −0.4%39.2K after | |
| Oct 6, 2023 (view filing)4:04 PM ET | Oct 4 | 2 days | Sapirstein JamesPresident and CEO | SSale | −2.76K | $0.29 | −$801.56 | −7.6%33.4K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Sapirstein JamesPresident and CEO | SSale | −3.35K | $1.54 | −$5.16K | −8.5%36.2K after | |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Sapirstein JamesPresident and CEO | SSale | −3.35K | $2.50 | −$8.37K | −7.8%39.5K after |